InvestorsHub Logo
Followers 14
Posts 730
Boards Moderated 0
Alias Born 12/09/2013

Re: None

Wednesday, 11/18/2015 10:13:23 AM

Wednesday, November 18, 2015 10:13:23 AM

Post# of 2933
ENTA/ABBV/GILD - QUARTZ-I: Retreatment of HCV Genotype 1 DAA-failures With
Ombitasvir/Paritaprevir/r, Dasabuvir, and Sofosbuvir

http://www.natap.org/2015/AASLD/AASLD_20.htm

93% SVR12 rate in past DAA exposures
Very small study; 22 patients
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News